New treatment strategy for Smith-Lemli-Opitz syndrome.
Jira
P
P
Wevers
R
R
de Jong
J
J
Rubio-Gozalbo
E
E
Smeitink
J
J
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D003684:Dehydrocholesterols / Q000097:blood; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007223:Infant; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019821:Simvastatin; D019082:Smith-Lemli-Opitz Syndrome / Q000188:drug therapy / Q000628:therapy*
D000924:Anticholesteremic Agents; D003684:Dehydrocholesterols; D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin; D019821:Simvastatin; C016705:7-dehydrocholesterol